IMDQ-PEG-cholesteryl monotherapy mounted a local anti-tumor immune response, characterized by infiltration of CD45+ cells and a high ratio of AH1+ CD8+ T cells in the tumor, that was sufficient to eradicate primary tumors. Here, PTPRC is linked to neoplasm.